BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 18330836)

  • 1. Axonal degeneration induced by intraneural injection of Campylobacter jejuni antiserum containing high titer anti-GM1 antibody.
    Shu XM; Cai FC; Zhang XP
    Neuropediatrics; 2007 Oct; 38(5):228-32. PubMed ID: 18330836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbohydrate mimicry of Campylobacter jejuni lipooligosaccharide is critical for the induction of anti-GM1 antibody and neuropathy.
    Shu XM; Cai FC; Zhang XP
    Muscle Nerve; 2006 Feb; 33(2):225-31. PubMed ID: 16270308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study on the role of parent Campylobacter jejuni and galE mutant in inducing experimental peripheral nerve damage].
    Shu XM; Cai FC; Zhang XP
    Zhonghua Er Ke Za Zhi; 2005 Apr; 43(4):256-60. PubMed ID: 15924714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sialic acid residue is a crucial component of C. jejuni lipooligosaccharide ganglioside mimicry in the induction Guillain-Barré syndrome.
    Xiang SL; Zhong M; Cai FC; Deng B; Zhang XP
    J Neuroimmunol; 2006 May; 174(1-2):126-32. PubMed ID: 16567003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome.
    Yuki N; Susuki K; Koga M; Nishimoto Y; Odaka M; Hirata K; Taguchi K; Miyatake T; Furukawa K; Kobata T; Yamada M
    Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11404-9. PubMed ID: 15277677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental axonopathy induced by immunization with Campylobacter jejuni lipopolysaccharide from a patient with Guillain-Barré syndrome.
    Caporale CM; Capasso M; Luciani M; Prencipe V; Creati B; Gandolfi P; De Angelis MV; Di Muzio A; Caporale V; Uncini A
    J Neuroimmunol; 2006 May; 174(1-2):12-20. PubMed ID: 16516981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunopathological evidence of terminal residues containing sialic acid in Campylobacter jejuni lipopolysaccharide as the critical antigen to induce peripheral neuropathy].
    Xiang SL; Cai FC; Zhang XP; Deng B
    Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):665-70. PubMed ID: 16191299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits.
    Ang CW; De Klerk MA; Endtz HP; Jacobs BC; Laman JD; van der Meché FG; van Doorn PA
    Infect Immun; 2001 Apr; 69(4):2462-9. PubMed ID: 11254608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies induced by ganglioside-mimicking Campylobacter jejuni lipooligosaccharides recognise epitopes at the nodes of Ranvier.
    Moran AP; Annuk H; Prendergast MM
    J Neuroimmunol; 2005 Aug; 165(1-2):179-85. PubMed ID: 15993494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of paranodal myelin detachment and sodium channel loss in vivo by Campylobacter jejuni DNA-binding protein from starved cells (C-Dps) in myelinated nerve fibers.
    Piao H; Minohara M; Kawamura N; Li W; Mizunoe Y; Umehara F; Goto Y; Kusunoki S; Matsushita T; Ikenaka K; Maejima T; Nabekura J; Yamasaki R; Kira J
    J Neurol Sci; 2010 Jan; 288(1-2):54-62. PubMed ID: 19880143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brucella melitensis infection associated with Guillain-Barré syndrome through molecular mimicry of host structures.
    Watanabe K; Kim S; Nishiguchi M; Suzuki H; Watarai M
    FEMS Immunol Med Microbiol; 2005 Aug; 45(2):121-7. PubMed ID: 16051063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monospecific high-affinity and complement activating anti-GM1 antibodies are determinants in experimental axonal neuropathy.
    Notturno F; Del Boccio P; Luciani M; Caporale CM; Pieragostino D; Prencipe V; Sacchetta P; Uncini A
    J Neurol Sci; 2010 Jun; 293(1-2):76-81. PubMed ID: 20382399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-GM1 IgG antibodies induce leukocyte effector functions via Fcgamma receptors.
    van Sorge NM; van den Berg LH; Geleijns K; van Strijp JA; Jacobs BC; van Doorn PA; Wokke JH; van de Winkel JG; Leusen JH; van der Pol WL
    Ann Neurol; 2003 May; 53(5):570-9. PubMed ID: 12730990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.
    Funakoshi K; Koga M; Takahashi M; Hirata K; Yuki N
    J Neurol Sci; 2006 Jul; 246(1-2):163-8. PubMed ID: 16600306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mimicry in Campylobacter jejuni: role of the lipo-oligosaccharide core oligosaccharide in inducing anti-ganglioside antibodies.
    Perera VN; Nachamkin I; Ung H; Patterson JH; McConville MJ; Coloe PJ; Fry BN
    FEMS Immunol Med Microbiol; 2007 Jun; 50(1):27-36. PubMed ID: 17374131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of humoral immune responses to LM1 ganglioside in guinea pigs.
    Gu Y; Chen ZW; Siegel A; Koshy R; Ramirez C; Raabe TD; Devries GH; Ilyas AA
    J Neuroimmunol; 2012 May; 246(1-2):58-64. PubMed ID: 22464399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathogenesis of axonal Guillain-Barré syndrome].
    Yuki N
    Rinsho Shinkeigaku; 2007 Jan; 47(1):1-7. PubMed ID: 17491330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
    Koga M; Takahashi M; Masuda M; Hirata K; Yuki N
    Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of bacterial risk factors for the development of Guillain-Barre syndrome after Campylobacter jejuni enteritis.
    Koga M; Gilbert M; Takahashi M; Li J; Koike S; Hirata K; Yuki N
    J Infect Dis; 2006 Feb; 193(4):547-55. PubMed ID: 16425134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome.
    Nachamkin I; Shadomy SV; Moran AP; Cox N; Fitzgerald C; Ung H; Corcoran AT; Iskander JK; Schonberger LB; Chen RT
    J Infect Dis; 2008 Jul; 198(2):226-33. PubMed ID: 18522505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.